Why Akso Health Group’s (AHG) Stock Is Up 10.05%
As of Wednesday, September 09, Akso Health Group’s AHG share price has surged by 10.05%, which has investors questioning if this is right time to sell.Omar Beirat
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Omar Beirat
Cynthia McLaughlin
Rosalio Madrigal
Rosalio Madrigal
Rosalio Madrigal
| Share Statistics | AHG | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $685.4 | $1,874.4 | 40% |
|
| Shares Out (Mil) | 856.3 | 76.7 | 93% |
|
| Institutional Ownership | na | 87.7% | na |
|
| Float (Mil) | 854.0 | 56.5 | 90% |
|
| Beta | -1.00 | 0.74 | 1% |
|
| Avg Daily Volume (000s) | 9 | 446 | 17% |
|
| Price Change (52-week) |
(52.9%) | 79.4% | 14% |
|
| Growth | AHG | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.4% | na |
|
| Net Income (5yr) | 11.7% | (0.2%) | 58% |
|
| EPS (5yr) | 57.4% | 3.0% | 95 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (23.9%) | (17.9%) | 27% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AHG | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $14 | $1,504 | 10% |
|
| Net Income (TTM) (Mil) | ($19) | $28 | 24% |
|
| EPS (TTM) | ($0.026) | $0.200 | 38% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | $162 | 18% |
|
| Net Cash Flow (TTM) (Mil) | na | $8 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $373 | 0% |
|
| Enterprise Value (Q1) (Mil) | $1,253 | $2,343 | 43% |
|
| Valuation | AHG | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.81 | 2.95 | 72% |
|
| P/E | na | 25.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | AHG | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (0.1%) | 27.8% | 4% |
|
| Net Margin | (135.0%) | 1.3% | 6% |
|
| ROA | (9.2%) | 2.2% | 26% |
|
| ROE | (9.8%) | 7.2% | 28% |
|
| Liabilities to Assets | 4.6% | 60.5% | 2% |
|
| F-Score | 4 | 5 | 33% |
|
Akso Health Group did not pass any screens on 9/9/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors